The NSDB leadership is staffed by a team of individuals whose collective backgrounds and expertise cover the broad multidisciplinary nature of cancer nanotechnology.
The mission of the Nanodelivery Systems and Devices Branch is to strategically develop, fund, and administer initiatives aimed at solving modern oncology problems with nanotechnology solutions.
The overarching goal of these initiatives is to discover and develop innovative nanotechnologies for application(s), ranging from discovery through to clinical translation phases, for the delivery of innovative clinically relevant technologies aimed at cancer prevention, diagnosis, control, and treatment.
